Herpes simplex virus infections of the newborn

Current Treatment Options in Neurology

Volumn 7, Issue 2, 2005, Pages 151-156

  Bale Jr , James F ^a   Miner, Lonnie J ^b  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSPHENYTOIN SODIUM; GRANULOCYTE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY; PHENOBARBITAL; PHENYTOIN; PROBENECID;

CAUSE OF DEATH; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DISEASE CLASSIFICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG TOLERABILITY; EYE INFECTION; HERPES SIMPLEX; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HUMAN; INFECTION PREVENTION; LONG TERM CARE; MENTAL DEFICIENCY; MORTALITY; MOUTH INFECTION; MUCOSA; NEPHROTOXICITY; NERVOUS SYSTEM DEVELOPMENT; NEUTROPENIA; NEWBORN; NEWBORN INFECTION; NEWBORN PERIOD; NONHUMAN; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; SEIZURE; SKIN INFECTION; SPEECH THERAPY;

EID: 14744302017     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-005-0024-0     Document Type: Review

References (25)

1. Stone K, Brooks C, Guinan M, et al.: National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis 1989, 16:152-156.
2. Kimberlin DW: Neonatal herpes simplex infection. Microbiol Rev 2004, 17:1-13.
3. Buchacz K, McFarland W, Hernandez M, et al.: Prevalence and correlates of herpes simplex virus type 2 infection in a population-based survey of young women in low-income neighborhoods of Northern California. The Young Women's Survey Team. Sex Transm Dis 2000, 27:393-400.
4. Armstrong GL, Schillinger J, Markowitz L, et al.: Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001, 153:912-920.
5. Fleming AL, McQuillan GM, Johnson RE, et al.: Herpes simplex virus type 1 in the United States, 1976 to 1994. N Engl J Med 1997, 337:1105-1111.
6. Sucato G, Celum C, Dithmer D, et al.: Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescents. Pediatr Infect Dis J 2001, 20:422-426.
7. Brown ZA, Selke S, Zeh J, et al.: The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997, 337:509-515.
8. Kimberlin DW, Lin C-Y, Jacobs RF, et al.: Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001, 108:223-229.
9. Hutto C, Arvin A, Jacobs R, et al.: Intrauterine herpes simplex virus infections. J Pediatr 1987, 110: 7-101.
10. Chalhub EG, Baenziger J, Feigen RD, et al.: Congenital herpes simplex type II infection with extensive hepatic calcification, bone lesions, and cataracts: complete post-mortem examination. Develop Med Child Neurol 1977, 19:527-534.
11. Grose C: Congenital infections caused by varicella zoster virus and herpes simplex virus. Sem Pediatr Neurol 1994, 1: 3-49.
12. Whitley RJ, Nahmias AJ, Visintine AM, et al.: The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980, 66:489-494.
13. Koskiniemi M, Happonen JM, Jarvenpaa AL, et al.: Neonatal herpes simplex virus infection: A report of 43 patients. Pediatr Infect Dis J 1989, 8:30-35.
14. Kimberlin DW: Herpes simplex virus, meningitis encephalitis in the neonate. Herpes 2004, 11(suppl 2): 5-76.
15. Kimberlin DW, Lakeman FD, Arvin AM, et al.: Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J Infect Dis 1996, 174:1162-1167.
16. Romero JR, Kimberlin DW: Molecular diagnosis of viral infections of the central nervous system. Clin Lab Med 2003, 23:843-865.
17. Kimberlin DW, Lin C-Y, Jacobs RF, et al.: Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001, 108: 30-238.
18. Brown ZA, Wald A, Morrow RA, et al.: Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003, 289: 03-209.
19. Whitley RJ, Nahmias AJ, Soong SJ, et al.: Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980, 66:495-501.
20. Whitley R, Arvin A, Prober C, et al.: A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991, 324:444-449.
21. Kimberlin DW: Advances in the treatment of neonatal herpes simplex virus infections. Rev Med Virol 2001, 11:157-163.
22. Kimberlin DW, Powell D, Gruber W, et al.: Administration of oral acyclovir suppressive therapy after neonatal herpes simplex disease limited to skin, eyes, and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996, 15:247-254.
23. Leung DT, Sacks SL: Current treatment options to prevent perinatal transmission of herpes simplex virus. Expert Opin Pharmacother 2003, 10:1809-1019.
24. Scott LL, Hollier LM, McIntire D, et al.: Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 2002, 10:71-77.
25. Brown Z: Preventing herpes simplex virus transmission to the neonate. Herpes 2004, 11 (Suppl 3):175A-186A.